Gradient Investments’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-25
Closed -$116 452
2024
Q2
$116 Buy
+25
New +$116 ﹤0.01% 1301